InsidersTradesSigma
Novonesis (Novozymes A/S) Stock: price and directors' dealings · Denmark · Finanstilsynet DK
Track the Novonesis (Novozymes A/S) share price and the full directors' dealings record of the company, a listed issuer based in Denmark. Shares trade on DK DK, under the supervision of Finanstilsynet DK. Operating in the Chemicals sector, Novonesis (Novozymes A/S) has published 175 reports. Market capitalisation: €172.5bn. The latest transaction was filed on 6 May 2021 (Purchase). Among the most active insiders: Unknown. Every trade is free.
175
Insider Decl.
0
Thresholds
€731m
11 ops.
Buy Volume
€1m
28 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Novonesis (Novozymes A/S) Buy (bullish), based on 17 analysts. Average price target: DKK 461.41.
28Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 13,579 of 26,179 companies
50.9
score / 100
Value37
Quality65
FCF yld0.4%
Earn yld0.3%
EV/EBITDA·
ROE5.4%
Gross mgn54%
Net mgn14%
Debt/EBITDA1.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 6 May 2021
Declarations175 total
ShareDK:1030267
Ideal exit: 31 Jan 2022 (T+270)
●
Unknown
The CEO of Novo Holdings A/S serves on the Board of Directors of Novozymes A/S, andExecutives
ShareDK:1029329
ShareDK:1028707
Ideal exit: 24 Jan 2022 (T+270)
ShareDK:921421
Ideal exit: 30 Jul 2021 (T+270)
ShareDK:920562
Ideal exit: 27 Jan 2021 (T+270)
ShareDK:920092
Ideal exit: 27 Nov 2020 (T+270)
ShareDK:919518
ShareDK:919174
Ideal exit: 24 Oct 2020 (T+270)
ShareDK:919041
ShareDK:919028
53,635 shares@ DKK 351.400.0015% mcap0.3% of flowShareDK:918790
●
Unknown
Novo Holdings A/S is a related party of Kasim Kutay, CEO of Novo Holdings A/S and aExecutives
ShareDK:909876
●
Unknown
Novo Holdings A/S is a related party of Kasim Kutay, CEO of Novo Holdings A/S and aExecutives
ShareDK:887279
ShareDK:851788
Ideal exit: 14 May 2019 (T+270)
●
Unknown
Novo Holdings A/S is a related party of Kasim Kutay, CEO of Novo Holdings A/S and aExecutives
ShareDK:840651
●
Unknown
Novo Holdings A/S is a related party of Kasim Kutay, CEO of Novo Holdings A/S and aExecutives
ShareDK:840289
●
Unknown
Novo Holdings A/S is a related party of Kasim Kutay, CEO of Novo Holdings A/S and aExecutives
ShareDK:840049
●
Unknown
Novo Holdings A/S is a related party of Kasim Kutay, CEO of Novo Holdings A/S and aExecutives
ShareDK:839827
●
Unknown
Novo Holdings A/S is a related party of Kasim Kutay, CEO of Novo Holdings A/S and aExecutives
ShareDK:839328
●
Unknown
Novo Holdings A/S is a related party of Kasim Kutay, CEO of Novo Holdings A/S and aExecutives
ShareDK:839001
●
Unknown
Novo Holdings A/S is a related party of Kasim Kutay, CEO of Novo Holdings A/SExecutives
ShareDK:838805
●
Unknown
Novo Holdings A/S is a related party of Kasim Kutay, CEO of Novo Holdings A/S and aExecutives
ShareDK:838486
●
Unknown
Novo Holdings A/S is a related party of Kasim Kutay, CEO of Novo Holdings A/S and aExecutives
ShareDK:838142
●
Unknown
Novo Holdings A/S is a related party of Kasim Kutay, CEO of Novo Holdings A/S and aExecutives
ShareDK:837880
ShareDK:837776
Ideal exit: 26 Jan 2019 (T+270)
25 of 175 declarations
About Novonesis (Novozymes A/S)
Novonesis is a subsidiary of Novozymes A/S, focused on developing enzymatic and biological solutions. The company emphasizes sustainable innovation for various sectors, including agriculture and food.